Acadia Healthcare Company, Inc. reported a revenue increase of 4.4% for the third quarter of 2025, totaling $851.6 million, compared to $815.6 million in the same period of 2024. For the nine months ending September 30, 2025, revenue reached $2.49 billion, up from $2.38 billion in the prior year, marking a 4.7% increase. The company's net income for the third quarter was $36.2 million, a decline from $68.1 million in the same quarter last year, while net income for the nine months was $74.7 million, down from $223.0 million in 2024. The decrease in profitability was attributed to increased operational costs, including salaries, wages, and benefits, which rose to $462.2 million in Q3 2025 from $428.1 million in Q3 2024.

In terms of operational metrics, Acadia Healthcare's same-facility revenue grew by 3.7% in Q3 2025, driven by a 3.3% increase in admissions and a 1.3% rise in patient days. The company operated 278 facilities with approximately 12,500 beds across 40 states and Puerto Rico as of September 30, 2025. The company added 908 beds during the nine months, including 634 beds from new facilities and expansions. The increase in operational capacity reflects Acadia's strategy to meet the growing demand for behavioral healthcare services.

Strategically, Acadia Healthcare has been active in acquisitions, including the purchase of Turning Point Centers, a 76-bed facility specializing in substance use disorder treatment, which was completed in February 2024. The company also reported significant transaction, legal, and other costs amounting to $42.9 million in Q3 2025, compared to $8.2 million in the same quarter of 2024, largely due to government investigations and restructuring costs. The company is currently navigating various legal challenges, including ongoing litigation related to past operations.

Financially, Acadia's total assets increased to $6.41 billion as of September 30, 2025, up from $5.96 billion at the end of 2024. The company’s long-term debt rose to $2.28 billion, reflecting new borrowings to support its expansion and operational needs. Cash provided by operating activities significantly improved to $218.2 million for the nine months ended September 30, 2025, compared to $13.0 million in the same period of 2024. The company also reported a cash balance of $118.7 million at the end of the third quarter.

Looking ahead, Acadia Healthcare remains focused on expanding its footprint and enhancing service offerings in the behavioral healthcare sector. The company plans to leverage its increased scale to pursue further growth opportunities through acquisitions and new facility openings. However, it continues to face challenges related to labor costs, regulatory scrutiny, and the integration of acquired operations, which may impact its financial performance in the near term.

About Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. operates a nationwide network of behavioral healthcare facilities, including acute inpatient psychiatric hospitals, specialty treatment centers, comprehensive treatment centers, and residential treatment centers. Serving patients with complex mental health and substance use disorders, Acadia provides a continuum of care through medical, therapeutic, and medication-assisted treatments. Its diversified revenue base includes Medicaid, Medicare, and commercial payors, supported by a scalable business model focused on facility ownership, partnerships, and acquisitions.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.